Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (81-90 of 231) with videos related to

Pageof 24
Sort By:
Vaccines|October 26, 2021
Shooting at a Moving Target-Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine DevelopmentFranziska Günl, Angeles Mecate-Zambrano, Selina Rehländer, et al.
Blood|January 13, 2004
Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cellsDorothee Viemann, Matthias Goebeler, Sybille Schmid, et al.
Mbio|November 7, 2013
Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagationAgnes Musiol, Sandra Gran, Christina Ehrhardt, et al.
The Journal of Infectious Diseases|August 29, 2013
New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variantSwantje Liedmann, Eike R Hrincius, Darisuren Anhlan, et al.
Biomed Research International|October 31, 2013
Proteinase-activated receptor-2 agonist activates anti-influenza mechanisms and modulates IFNγ-induced antiviral pathways in human neutrophilsMicha Feld, Victoria Shpacovitch, Christina Ehrhardt, et al.
Cellular Microbiology|August 3, 2006
Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defenceChristina Ehrhardt, Henju Marjuki, Thorsten Wolff, et al.
Antiviral Research|April 6, 2017
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivoEmanuel Haasbach, Christin Müller, Christina Ehrhardt, et al.
Journal of Ethnopharmacology|May 15, 2016
Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virusAndrea Derksen, Joachim Kühn, Wali Hafezi, et al.
Npj Viruses|April 28, 2025
Metabolic interference impairs influenza A virus replication by dampening vRNA synthesisJens Kleinehr, Chiara Robin Bojarzyn, Michael Schöfbänker, et al.
Journal of Virology|September 27, 2003
Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complexOliver Planz, Stephan Pleschka, Katja Oesterle, et al.
Pageof 24

Showing results (81-90 of 231) with videos related to

Sort By:
Pageof 24
Vaccines|October 26, 2021
Shooting at a Moving Target-Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine DevelopmentFranziska Günl, Angeles Mecate-Zambrano, Selina Rehländer, et al.
Blood|January 13, 2004
Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cellsDorothee Viemann, Matthias Goebeler, Sybille Schmid, et al.
Mbio|November 7, 2013
Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagationAgnes Musiol, Sandra Gran, Christina Ehrhardt, et al.
The Journal of Infectious Diseases|August 29, 2013
New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variantSwantje Liedmann, Eike R Hrincius, Darisuren Anhlan, et al.
Biomed Research International|October 31, 2013
Proteinase-activated receptor-2 agonist activates anti-influenza mechanisms and modulates IFNγ-induced antiviral pathways in human neutrophilsMicha Feld, Victoria Shpacovitch, Christina Ehrhardt, et al.
Cellular Microbiology|August 3, 2006
Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defenceChristina Ehrhardt, Henju Marjuki, Thorsten Wolff, et al.
Antiviral Research|April 6, 2017
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivoEmanuel Haasbach, Christin Müller, Christina Ehrhardt, et al.
Journal of Ethnopharmacology|May 15, 2016
Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virusAndrea Derksen, Joachim Kühn, Wali Hafezi, et al.
Npj Viruses|April 28, 2025
Metabolic interference impairs influenza A virus replication by dampening vRNA synthesisJens Kleinehr, Chiara Robin Bojarzyn, Michael Schöfbänker, et al.
Journal of Virology|September 27, 2003
Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complexOliver Planz, Stephan Pleschka, Katja Oesterle, et al.
Pageof 24